Multi-centric prospective and randomized Study to Investigate the Effectiveness of Radiation Therapy based on the Dosage in Patients with painful Arthrosis. ARTHTORAD Study - First Results of an Interim Analysis

被引：0
|
作者：
Niewald, M. [1 ]
Mueller, L. [1 ]
Hautmann, M. G. [2 ]
Dzierma, Y. [1 ]
Melchior, P. [1 ]
Graber, S. [3 ]
Ruebe, C. [1 ]
机构：
[1] Univ Klinikum Saarlandes, Klin Strahlentherapie & Radioonkol, Homburg, Germany
[2] Univ Klinikum Regensburg, Klin & Poliklin Strahlentherapie, Regensburg, Germany
[3] Univ Klinikum Saarlandes, Inst Med Biometrie Epidemiol & Med Inform, Homburg, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2019年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
VS01-4
引用
下载
收藏
页码：S6 / S7
页数：2
相关论文
共 50 条
  • [41] AUO-study on metastatic renal cell carcinoma A prospective randomized multi-centric Phase 2 study of the metastatic resection of pulmonary metastases of the clear cell renal cell carcinoma ± adjuvant Sunitinib therapy over 1 year (SMAT-AN 20/04 of AUO)
    Rexer, H.
    UROLOGE, 2011, 50 (01): : 83 - 84
  • [42] Correct -: Interim analysis of a web-based observational study on the effectiveness of darbepoetin alfa therapy in anemic patients with non-myeloic cancers receiving chemotherapy
    Lerchenmueller, C.
    Eggert, J.
    Chatsiproios, D.
    Maasberg, M.
    Schmidt, B.
    Verpoort, K.
    Hellebrand, E.
    Tesch, H.
    Steinmetz, T.
    ONKOLOGIE, 2008, 31 : 166 - 166
  • [43] First Interim Analysis of ALPINE Study: Results of a Phase 3 Randomized Study of Zanubrutinib vs Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
    Brown, Jennifer R.
    Hillmen, Peter
    Eichhorst, Barbara
    Lamanna, Nicole
    O'Brien, Susan
    Tam, Constantine S.
    Qiu, Lugui
    Kazmierczak, Maciej
    Zhou, Keshu
    Simkovic, Martin
    Mayer, Jiri
    Gillespie-Twardy, Amanda
    Shadman, Mazyar
    Ferrajoli, Alessandra
    Ganly, Peter S.
    Weinkove, Robert
    Salmi, Tommi
    Wu, Kenneth
    Novotny, William
    Jurczak, Wojciech
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S266 - S266
  • [44] Atezolizumab and Stereotactic Body Radiation Therapy in Metastatic, Recurrent or Persistent Cervical Cancer: Interim Results from a Non-Randomized, Open-Label Phase II Multi-Institutional Study
    Ahmed, K. A.
    Quick, A. M.
    Bixel, K.
    Kim, Y.
    Lemerond, E.
    Chon, H. S.
    Chern, J. Y.
    Fernandez, D. C.
    Hoffman, M. S.
    Kim, S.
    Lam, C.
    Montejo, M. E.
    Shahzad, M. M.
    Wenham, R. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S89 - S90
  • [45] Cost-effectiveness of proton beam therapy vs. conventional radiotherapy for patients with brain tumors in Sweden: results from a non-randomized prospective multicenter study
    Sampaio, Filipa
    Langegard, Ulrica
    de Alva, Patricio Martinez
    Flores, Sergio
    Nystrand, Camilla
    Fransson, Per
    Ohlsson-Nevo, Emma
    Kristensen, Ingrid
    Sjovall, Katarina
    Feldman, Inna
    Ahlberg, Karin
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2024, 22 (01):
  • [46] Early Nutrition Support Therapy to Improve the Nutrition Status of Head and Neck Cancer Patients Accepted Concurrent Chemoradiotherapy(NSTIP): Interim Analysis from a Prospective Randomized Controlled Clinical Study
    Zhang, P.
    Xie, K.
    Huang, X.
    Li, C.
    Song, Y.
    Li, B.
    Liao, W.
    Zhang, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E744 - E745
  • [47] Early nutrition support therapy to improve the nutrition status of head and neck cancer patients accepted concurrent chemoradiotherapy (NSTIP): Interim analysis from a prospective randomized controlled clinical study
    Zhang, Peng
    Xie, Kang
    Huang, Xuemei
    Li, Rong Chu
    Song, Yanqiong
    Li, Baisen
    Liao, Wenjun
    Zhang, Shichuan
    Lang, Jinyi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis
    Necchi, Andrea
    Giannatempo, Patrizia
    Raggi, Daniele
    Mariani, Luigi
    Colecchia, Maurizio
    Fare, Elena
    Monopoli, Francesco
    Calareso, Giuseppina
    Ali, Siraj M.
    Ross, Jeffrey S.
    Chung, Jon H.
    Salvioni, Roberto
    EUROPEAN UROLOGY, 2019, 75 (01) : 201 - 203
  • [49] First Interim Results of the PERFORM Study for Evaluating First-line Endocrine-based Palbociclib Therapy for Patients with HR+/ HER2-advanced Breast Cancer in the Real World
    Fietz, T.
    Wilke, J.
    Deryal, M.
    Gabrysiak, T.
    Schoettker, B.
    Jacobasch, L.
    Petersen, V
    Weigel, M.
    Wrobel, D.
    Glastetter, E.
    Berger, L.
    Frank, M.
    Woerner, S. M.
    Adams, A.
    Woeckel, A.
    Lux, M. P.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 108 - 108
  • [50] A Prospective, Observational Registry Study to Evaluate Effectiveness and Safety of Hyaluronic Acid-Based Dermal Fillers in Routine Practice: Interim Analysis Results with One Year of Subject Follow-Up
    Bhojani-Lynch, Tahera
    Deckers, Anne
    Ohanes, Ohan
    Poupard, Kevin
    Maffert, Pauline
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2021, 14 : 1685 - 1695
12345